Roles of 3,4-methylenedioxymethamphetamine (MDMA)-induced alteration of connexin43 and intracellular Ca(2+) oscillation in its cardiotoxicity.

[1]  Mario Delmar,et al.  Cardiac connexins, mutations and arrhythmias , 2012, Current opinion in cardiology.

[2]  R. Gourdie,et al.  Enhanced PKCε mediated phosphorylation of connexin43 at serine 368 by a carboxyl-terminal mimetic peptide is dependent on injury , 2011, Channels.

[3]  R. Gourdie,et al.  A Peptide Mimetic of the Connexin43 Carboxyl Terminus Reduces Gap Junction Remodeling and Induced Arrhythmia Following Ventricular Injury , 2011, Circulation research.

[4]  S. Sadayappan,et al.  In vivo and in vitro cardiac responses to beta-adrenergic stimulation in volume-overload heart failure. , 2010, Journal of molecular and cellular cardiology.

[5]  S. Bello,et al.  Myocardial expression of TNF-alpha, IL-1beta, IL-6, IL-8, IL-10 and MCP-1 after a single MDMA dose administered in a rat model. , 2010, Current pharmaceutical biotechnology.

[6]  S. Bello,et al.  MDMA toxicity and pathological consequences: a review about experimental data and autopsy findings. , 2010, Current pharmaceutical biotechnology.

[7]  J. Haefliger,et al.  An angiotensin II- and NF-kappaB-dependent mechanism increases connexin 43 in murine arteries targeted by renin-dependent hypertension. , 2010, Cardiovascular research.

[8]  M. Nasr-Esfahani,et al.  Toxicity of ecstasy (MDMA) towards embryonic stem cell-derived cardiac and neural cells. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  L. Gandía,et al.  The effects of 3,4-methylenedioxymethamphetamine (MDMA) on nicotinic receptors: intracellular calcium increase, calpain/caspase 3 activation, and functional upregulation. , 2010, Toxicology and applied pharmacology.

[10]  P. Lampe,et al.  Connexin43 phosphorylation: structural changes and biological effects. , 2009, The Biochemical journal.

[11]  F. Carvalho,et al.  Metabolites of MDMA Induce Oxidative Stress and Contractile Dysfunction in Adult Rat Left Ventricular Myocytes , 2009, Cardiovascular Toxicology.

[12]  Seungho Wang,et al.  Effects of 18‐glycyrrhetinic acid on serine 368 phosphorylation of connexin43 in rat neonatal cardiomyocytes , 2008, Cell biology international.

[13]  M. Neri,et al.  Cardiac oxidative stress determination and myocardial morphology after a single ecstasy (MDMA) administration in a rat model , 2008, International Journal of Legal Medicine.

[14]  Liang Liu,et al.  Aconitine alters connexin43 phosphorylation status and [Ca2+] oscillation patterns in cultured ventricular myocytes of neonatal rats. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[15]  J. Saffitz,et al.  Protein kinase Cε mediates salutary effects on electrical coupling induced by ischemic preconditioning , 2007 .

[16]  Mark von Zastrow,et al.  Microtubule Plus-End-Tracking Proteins Target Gap Junctions Directly from the Cell Interior to Adherens Junctions , 2007, Cell.

[17]  P. Lampe,et al.  Selectivity of Connexin 43 Channels Is Regulated Through Protein Kinase C–Dependent Phosphorylation , 2006, Circulation research.

[18]  F. Schifano,et al.  Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994–2003) , 2006, Journal of psychopharmacology.

[19]  R. Böhm,et al.  Hyperdynamer Kreislaufstillstand nach Ingestion von Ecstasy , 2005 .

[20]  G. Morley,et al.  Cardiac-Specific Loss of N-Cadherin Leads to Alteration in Connexins With Conduction Slowing and Arrhythmogenesis , 2005, Circulation research.

[21]  S. Elliott.  MDMA and MDA concentrations in antemortem and postmortem specimens in fatalities following hospital admission. , 2005, Journal of analytical toxicology.

[22]  D. Laird.  Connexin phosphorylation as a regulatory event linked to gap junction internalization and degradation. , 2005, Biochimica et biophysica acta.

[23]  Xin Xu,et al.  Connexin43 Associated with an N-cadherin-containing Multiprotein Complex Is Required for Gap Junction Formation in NIH3T3 Cells* , 2005, Journal of Biological Chemistry.

[24]  M. Rosen,et al.  Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytes. , 2005, Cardiovascular research.

[25]  P. Lampe,et al.  The effects of connexin phosphorylation on gap junctional communication. , 2004, The international journal of biochemistry & cell biology.

[26]  Fabrizio Schifano,et al.  A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities , 2004, Psychopharmacology.

[27]  E. Fernandes,et al.  Metabolism is required for the expression of ecstasy-induced cardiotoxicity in vitro. , 2004, Chemical research in toxicology.

[28]  R. de la Torre,et al.  Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. , 2004, Therapeutic drug monitoring.

[29]  M. C. Brañes,et al.  Plasma membrane channels formed by connexins: their regulation and functions. , 2003, Physiological reviews.

[30]  M. Colado,et al.  The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) , 2003, Pharmacological Reviews.

[31]  K. Varner,et al.  Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of Ecstasy. , 2002, The Journal of pharmacology and experimental therapeutics.

[32]  F. Fornai,et al.  Ecstasy during loud noise exposure induces dramatic ultrastructural changes in the heart. , 2002, Pharmacology & toxicology.

[33]  M. Landry.  MDMA: A Review of Epidemiological Data , 2002, Journal of psychoactive drugs.

[34]  P A Insel,et al.  Protein kinase C isozymes and the regulation of diverse cell responses. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[35]  P. O'cain,et al.  Cardiovascular and sympathetic responses and reflex changes elicited by MDMA , 2000, Physiology & Behavior.

[36]  P. Lampe,et al.  Phosphorylation of Connexin43 on Serine368 by Protein Kinase C Regulates Gap Junctional Communication , 2000, The Journal of cell biology.

[37]  E. Hertzberg,et al.  Use of antibodies in the analysis of connexin 43 turnover and phosphorylation. , 2000, Methods.

[38]  R. de la Torre,et al.  Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. , 1999, The Journal of pharmacology and experimental therapeutics.

[39]  G. Beitia,et al.  3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: effect on cytosolic calcium signals in isolated hepatocytes. , 1999, Liver.

[40]  A. Maio,et al.  Downregulation of connexin 43 gene expression in rat heart during inflammation. The role of tumour necrosis factor. , 1999, Cytokine.

[41]  S. Dhein.  Gap junction channels in the cardiovascular system: pharmacological and physiological modulation. , 1998, Trends in pharmacological sciences.

[42]  P. Parker,et al.  The extended protein kinase C superfamily. , 1998, The Biochemical journal.

[43]  A. Nairn,et al.  Phosphorylation of connexin43 and the regulation of neonatal rat cardiac myocyte gap junctions. , 1997, Journal of molecular and cellular cardiology.

[44]  A. Forrest,et al.  Pathology of deaths associated with "ecstasy" and "eve" misuse. , 1996, Journal of clinical pathology.

[45]  G. Goodwin,et al.  Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”) , 1995, Psychopharmacology.

[46]  K. Willecke,et al.  Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells , 1995, The Journal of cell biology.

[47]  S. Dawling,et al.  Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy") , 1992, The Lancet.

[48]  E. Azmitia,et al.  MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2+-dependent toxicity linked to release , 1990, Brain Research.

[49]  B. Yamamoto,et al.  Acute and subchronic effects of methylenedioxymethamphetamine [(±)MDMA] on locomotion and serotonin syndrome behavior in the rat , 1989, Pharmacology Biochemistry and Behavior.

[50]  R. Riemersma,et al.  "Ecstasy" and sudden cardiac death. , 1988, The American journal of forensic medicine and pathology.

[51]  M. Geyer,et al.  Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[52]  R. Bost,et al.  'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA. , 1987, JAMA.

[53]  B. Horecker,et al.  Binding of protein kinase C to neutrophil membranes in the presence of Ca2+ and its activation by a Ca2+-requiring proteinase. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[54]  R. Rothman,et al.  Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA). , 2009, International review of neurobiology.

[55]  N. Tribulova,et al.  Myocardial gap junctions: targets for novel approaches in the prevention of life-threatening cardiac arrhythmias. , 2008, Physiological research.

[56]  S. Beebe,et al.  3,4-Methylenedioxymethamphetamine activates nuclear factor-κB, increases intracellular calcium, and modulates gene transcription in rat heart cells , 2007, Cardiovascular Toxicology.

[57]  C. Sterk,et al.  Ecstasy and gateway drugs: initiating the use of ecstasy and other drugs. , 2007, Annals of epidemiology.

[58]  Robert D. Goldman,et al.  Cells: a laboratory manual , 1997 .

[59]  R Kemler,et al.  N-cadherin in adult rat cardiomyocytes in culture. II. Spatio-temporal appearance of proteins involved in cell-cell contact and communication. Formation of two distinct N-cadherin/catenin complexes. , 1996, Journal of cell science.

[60]  W. Slikker,et al.  Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate. , 1989, Neurotoxicology.